Alvotech Holdings S.A.: Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination

Business Combination anticipated to close on or about June 15, 2022 Ordinary shares of Alvotech expected to trade under the new ticker symbol "ALVO" from June 16, 2022 on The Nasdaq Stock

Related Keywords

California ,United States ,New York ,Yangtze River ,China General ,China ,Malaysia ,Australia ,Taiwan ,Japan ,Philippines ,Hong Kong ,Vietnam ,Republic Of ,Indonesia ,Pakistan ,Iceland ,Bangladesh ,India ,Thailand ,New Zealand ,Israel ,Singapore ,Cambodia ,Reykjavik ,C10 ,South Korea ,Stephanie Carrington ,Africa ,Saval Latin America ,Robert Wessman ,Los Angeles ,Sean Leous ,Kostenloser Wertpapierhandel ,Zaid Pardesi ,Kamada Ltd ,Alvotech Lux Holdings ,Lotus Pharmaceuticals Co Ltd ,Exchange Commissiona Registration Statement On Form ,Pharma Corporation Canada ,Nasdaq ,Teva Pharmaceuticals ,Oaktree Acquisition Corp ,Fuji Pharma Co Ltd ,Teva Pharmaceutical Industries Ltd ,Alvotech Holdings Sa ,Corporate Communications ,Nasdaq Stock Market ,Yangtze River Pharmaceutical Group Co Ltd ,Cipla ,Business Combination ,Nasdaq First North Growth Market ,Oaktree Acquisition ,Oaktree Capital Management ,Extraordinary General Meeting ,South America ,Teva Pharmaceutical Industries ,Cipla Med Pro ,Yangtze River Pharmaceutical ,Middle East ,North Africa ,Abdi Ibrahim ,Mega Labs ,Latin America ,Exchange Commission ,Registration Statement ,Grand Avenue ,Nasdaq First North Growth ,Note Regarding Forward Looking ,Securities Act ,Alvotech ,Oldings ,0aktree ,Cquisition ,Orp ,Nnounce ,Shareholder ,Approval ,Business ,Combination ,